CorMedix Executives Sell Shares
Less than 1 min read
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Hurlburt Elizabeth | Chief Operating Officer | Sell | $711,817 | Form 4 |
| Zelnick Kaufman Beth | Chief Legal Officer | Sell | $670,264 | Form 4 |
Elizabeth Hurlburt, Chief Operating Officer of CorMedix, sold 53,997 shares of Common Stock on September 9 and September 11, 2025, at weighted average prices of $13.51 and $13.08 per share, respectively, totaling $711,817. Following these transactions, Hurlburt directly owns 176,990 shares of the company.
Beth Zelnick Kaufman, Chief Legal Officer of CorMedix, sold 50,000 shares of common stock on September 9, 2025, at a weighted average price of $13.41, with the sale amounting to $670,264. Prices ranged from $12.83 to $13.82. After the sale, Kaufman directly owns 180,418 shares.